Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-omics Analyses of Airway Host-microbiome Interaction in Chronic Obstructive Pulmonary Disease and Bronchiectasis Identify Potential Therapeutic Interventions

NCT05738044 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05738044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05738044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-omics Analyses of Airway Host-microbiome Interaction in Chronic Obstructive Pulmonary Disease and Bronchiectasis Identify Potential Therapeutic Interventions
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2023
Completion date
June 30, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis with acute exacerbation, copd exacerbation